Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANNEXA-4
DRKS00012316Phase 3Completed
- Sponsor
- Portola Pharmaceuticals
- Start
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
Phase 3, open-label, single-arm trial of andexanet alfa in Acute major hemorrhage, sponsored by Portola Pharmaceuticals. Started Aug 2017; status: completed.
02
Drugs
andexanet alfa
03
Conditions
Acute major hemorrhage
Beyond the preview
Go deeper on DRKS00012316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012316.